-
Wednesday's Put/Call Ratio Leaders
Wednesday, August 10, 2011 - 11:35am | 78Here are today's Put/Call Ratio leaders… 1. Universal Health Services (NYSE: UHS) 5,368 puts, 3 calls 2. Central European Distribution (NASDAQ: CEDC) 4,308 puts, 12 calls 3. Equity Residential (NYSE: EQR) 2,508 puts, 32 calls 4. News Corp. (NASDAQ: NWSA) 7,064 puts, 203 calls 5. Paychex (NASDAQ:...
-
UPDATE: Jefferies Lowers PT on RadNet to $3.50
Wednesday, August 10, 2011 - 7:39am | 90Jefferies is out with its report today on RadNet (NASDAQ: RDNT), lowering its PT to $3.50 from $4.50. In its report, Jefferies writes, "We are adjusting our PT to $3.50 to reflect our view that investor aversion toward microcap stocks is high at the moment given elevated levels of equity market...
-
Jefferies Lowers PT on RadNet To $3.50
Wednesday, August 10, 2011 - 5:45am | 26Jefferies & Company has lowered the price target on RadNet (NASDAQ: RDNT) from $4.50 to $3.50 and maintains its Hold rating.
-
UPDATE: Bank of America Merrill Lynch Lowers PO on Kindred Healthcare to $15
Tuesday, August 9, 2011 - 7:49am | 94Bank of America Merrill Lynch is out with its report today on Kindred Healthcare (NYSE: KND), lowering its PO to $15 from $20. In its report, Bank of America Merrill Lynch writes, "Our $15 PO represents 6.4x our 2012 EBITDAR estimate of $907m. The 6.4x would be in the middle of the historical...
-
Bank of America Lowers PO On Kindred Healthcare To $15
Tuesday, August 9, 2011 - 7:13am | 28Bank of America has lowered the price objective on Kindred Healthcare (NYSE: KND) from $20 to $15 and maintains its Neutral rating.
-
UPDATE: Jefferies Lowers PT on Kindred Healthcare to $13
Tuesday, August 9, 2011 - 6:43am | 79Jefferies is out with its report today on Kindred Healthcare (NYSE: KND), lowering its PT to $13 from $20. In its report, Jefferies writes, "Macroeconomic concerns along with renewed reimbursement fears will likely keep KND's stock range-bound for now, despite solid Q2 results and an attractive...
-
UPDATE: J.P. Morgan Lowers PT on Kindred Healthcare to $15
Tuesday, August 9, 2011 - 6:38am | 98J.P. Morgan is out with its report today on KIndred Healthcare (NYSE: KND), lowering its PT to $15 from $30. In its report, J.P. Morgan writes, "We are establishing our December 2012 price target at $15/share, our prior December 2011 price target was $30. Our new price target is based on 6x our...
-
Morgan Keegan Lowers PT on Brookdale Senior Living from $30 to $21
Tuesday, August 9, 2011 - 6:18am | 97Morgan Keegan has published a report on Brookdale Senior Living (NYSE: BKD) lowering the price target. In the report, Morgan Keegan wrote, "We are lowering our cash from facility operations (CFFO) estimate for Brookdale Senior Living for the third time since the beginning of the June following the...
-
Jefferies Lowers PT On Kindred Healthcare To $13
Tuesday, August 9, 2011 - 5:46am | 27Jefferies & Company has lowered the price target on Kindred Healthcare (NYSE: KND) from $20 to $13 and maintains its Hold rating.
-
JP Morgan Lowers PT On Kindred Healthcare To $15
Tuesday, August 9, 2011 - 5:27am | 27JP Morgan has lowered the price target on Kindred Healthcare (NYSE: KND) from $30 to $15 and maintains its Overweight rating.
-
Morgan Keegan Lowers PT On Brookedale Senior Living To $21
Tuesday, August 9, 2011 - 5:11am | 28Morgan Keegan has lowered the price target on Brookdale Senior Living (NYSE: BKD) from $30 to $21 and maintains its Outperform rating.
-
Tenet Announces East Cooper Medical Center Appoints New Hospital CEO
Monday, August 8, 2011 - 9:02am | 122Tenet Healthcare Corporation (NYSE: THC) today announced that East Cooper Medical Center has appointed Jason Alexander as its new chief executive officer. As CEO, Alexander will oversee strategic, operational and clinical activities for the 140-bed acute-care hospital in Mount Pleasant, S.C. “We...
-
UPDATE: Stifel Nicolaus Lowers PT on Emeritus to $25
Monday, August 8, 2011 - 7:52am | 112Stifel Nicolaus is out with its report today on Emeritus (NYSE: ESC), lowering its PT to $25 from $30. In its report, Stifel Nicolaus writes, "Emeritus' 2Q11 CFFO per share bested our estimate but the company posted disappointing QoQ and YoY same-store results. ESC shares down 32.2% since 3/31/11...
-
UPDATE: Morgan Keegan Lowers PT on Emeritus to $24
Friday, August 5, 2011 - 7:07am | 91Morgan Keegan is out with its report today on Emeritus (NYSE: ESC), lowering its PT from $29 to $24. In its report, Morgan Keegan writes, "Our model reflects both the weaker-than-expected operating metrics and the Medicare cut. We are lowering our 2011 cash from facility operations estimate from $...
-
Morgan Keegan Lowers PT On Emeritus To $24
Friday, August 5, 2011 - 5:12am | 27Morgan Keegan has lowered the price target on Emeritus Corporation (NYSE: ESC) from $29 to $24 and maintains its Outperform rating.